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“Schizotypy” is a latent organization of personality related to the genetic risk for
schizophrenia. Some evidence suggests that schizophrenia and schizotypy share some
biological features, including a link to dopaminergic D2 receptor signaling. A polymorphism
in the D2 gene (DRD2 rs1076560, guanine > thymine (G > T)) has been associated
with the D2 short/long isoform expression ratio, as well as striatal dopamine signaling
and prefrontal cortical activity during different cognitive operations, which are measures
that are altered in patients with schizophrenia. Our aim is to determine the association
of schizotypy scores with the DRD2 rs1076560 genotype in healthy individuals and
their interaction with prefrontal activity during attention and D2 striatal signaling. A
total of 83 healthy subjects were genotyped for DRD2 rs1076560 and completed the
Schizotypal Personality Questionnaire (SPQ). Twenty-six participants underwent SPECT
with [123I]IBZM D2 receptor radiotracer, while 68 performed an attentional control task
during fMRI. We found that rs1076560 GT subjects had greater SPQ scores than GG
individuals. Moreover, the interaction between schizotypy and the GT genotype predicted
prefrontal activity and related attentional behavior, as well as striatal binding of IBZM. No
interaction was found in GG individuals. These results suggest that rs1076560 GT healthy
individuals are prone to higher levels of schizotypy, and that the interaction between
rs1076560 and schizotypy scores modulates phenotypes related to the pathophysiology
of schizophrenia, such as prefrontal activity and striatal dopamine signaling. These results
provide systems-level qualitative evidence for mapping the construct of schizotypy in
healthy individuals onto the schizophrenia continuum.
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INTRODUCTION
Schizophrenia is strongly heritable. The risk for schizophrenia
can be represented by a continuous Gaussian distribution in the
general population (Plomin, 1999) with an arbitrary threshold to
distinguish patients and healthy individuals (DSM-V diagnostic
criteria) (Bhati, 2013). In light of this, people falling within this
distribution and below the threshold still have some theoretical
risk for the disease but do not manifest it. A corollary of this
perspective is that individuals below the diagnostic threshold also
share some of the genetic risk for the disorder (Plomin, 1999).
“Schizotypy” is a latent organization of personality including
both positive and negative attenuated symptoms of schizophrenia
(Meehl, 1989). Higher rates of schizotypal traits have been found
in first-degree relatives of patients with schizophrenia compared
with healthy subjects, suggesting that schizotypy is related to a
genetic risk for the disorder (Kety et al., 1994; Kendler et al.,
1995; Tsuang et al., 1999; Vollema et al., 2002; Ettinger et al.,
2014). Nonetheless, variable schizotypy has been found in non-
psychiatric individuals (Chen et al., 1997; Croft et al., 2001;
Fonseca-Pedrero et al., 2007, 2008, 2009, 2011; Aguirre et al.,
2008; Kwapil et al., 2008; Noguchi et al., 2008; Wilson et al.,
2008; Bedwell et al., 2009), suggesting that this trait may be
studied in healthy subjects without the confounds and limitations
commonly found in patients.
Schizotypy has been correlated with neurocognitive, behav-
ioral, and social deficits, which are qualitatively similar to those
found in patients with schizophrenia but quantitatively less severe
(Croft et al., 2001; Noguchi et al., 2008; Wilson et al., 2008;
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Bedwell et al., 2009; Giakoumaki, 2012). For example, deficits
in cognitive flexibility, working memory, and prepulse inhibition
have been consistently reported in healthy subjects with high
schizotypy (Giakoumaki, 2012). These findings suggest that risk
for schizophrenia, schizotypy, and cognitive abnormalities may be
interconnected. Indeed, previous studies have demonstrated that
dopamine and D2 receptor are implicated both in schizotypy and
risk for schizophrenia, as well as in schizophrenia-related pheno-
types, including attentional deficits and associated brain physiol-
ogy (Zhang et al., 2007; Delawalla et al., 2008; Blasi et al., 2010).
In this context, consistent evidence suggests abnormal dopamine
signaling in the striatal regions (Abi-Dargham et al., 1998, 2000)
particularly in the putamen (Soret et al., 2003; Scherfler et al.,
2005; Kegeles et al., 2010; Suridjan et al., 2013) of patients with
schizophrenia and of subjects at high risk for this brain disor-
der. Furthermore, striatal dopamine release positively correlated
with schizotypal personality traits in healthy subjects in a PET
study (Woodward et al., 2011). A recent single-photon emission
computed tomography (SPECT) investigation revealed that the
availability of striatal D2 receptors is associated with schizotypal
features in healthy volunteers (Chen et al., 2012). Finally, another
study in patients with schizotypal personality disorder (SPD)
indicated exaggerated dopamine release in the striatum following
d-amphetamine challenge (Abi-Dargham et al., 2004). However,
more investigation of the function of brain networks is needed to
map schizotypy in healthy individuals onto the Gaussian distri-
bution of schizophrenia risk.
Genetic risk for schizophrenia has been widely investigated in
a number of association studies, but there is still little evidence
confirming the association of the dopamine D2 receptor (DRD2)
gene with the disease (Allen et al., 2008). More recent data
from the Psychiatric Genomic Consortium seem to indicate a
strong association between DRD2 and schizophrenia in the largest
sample studied to date (Ripke et al. oral communication, World
Congress Psychiatric Genetics, Boston 2013). Moreover, some
of the strongest candidate genes for schizophrenia, including
ZNF804A, DISC1, and DTNBP1, have well-known biological
effects on D2 receptors or D2 signaling partners (Marley and
von Zastrow, 2010; Girgenti et al., 2012; Papaleo et al., 2012).
Also, D2 receptors have consistently been implicated in the phar-
macodynamic mechanism of antipsychotic drugs (Carpenter and
Koenig, 2008), which are the only medications with established
effectiveness in schizophrenia (Carpenter and Koenig, 2008).
The DRD2 gene is transcribed into two main mRNA isoforms,
resulting in as many proteins: D2 short (S) and D2 long (L).
D2L receptors mainly mediate post-synaptic signaling, whereas
D2S receptors mainly serve as auto-receptors on pre-synaptic
neurons (Usiello et al., 2000). The intronic DRD2 polymorphism
rs1076560 (guanine > thymine (G> T)) is associated with mRNA
splicing (Zhang et al., 2007). More specifically, the minor (T)
allele is associated with a lower ratio of the expression between
D2S and D2L in the post-mortem prefrontal cortex and striatum,
as well as with altered activity of the striato-thalamic-prefrontal
pathway during tasks probing different brain functions (Zhang
et al., 2007; Bertolino et al., 2009a,b, 2010; Blasi et al., 2009, 2011).
More recently, we have demonstrated that the effect of this single
nucleotide polymorphism (SNP) on prefrontal cortical activity
during cognition may also be associated with indirect modulation
of dopamine D2 signaling via the striatum (Bertolino et al.,
2010). Importantly, the association between dopamine-related
genetic variation and brain function shows its impact on some
core phenotypes of schizophrenia, such as attentional processing
and related cingulate and prefrontal activity (Blasi et al., 2005,
2007, 2010, 2011; Delawalla et al., 2008; Weickert et al., 2009).
Altogether, this evidence strongly suggests a relationship between
D2 receptor genetic variability, attentional processes, and risk for
schizophrenia. Notably, schizotypy is also associated with deficits
in attention. In fact, two different studies have reported a cor-
relation between this trait and behavioral abnormalities during
attentional processing (Breeze et al., 2011; Giakoumaki, 2012).
However, to our knowledge, there has been no functional imaging
study investigating the relationship between schizotypy and brain
activity during attention, as well as its putative interaction with
the DRD2 gene.
Based on this evidence, we aim to:
1. Determine the association of schizotypy scores with DRD2
rs1076560 genotype in healthy individuals.
2. Investigate how schizotypy and the DRD2 rs1076560 genotype
interact on prefrontal activity during attention and D2 striatal
signaling in healthy subjects.
MATERIALS AND METHODS
SUBJECTS
A total of 83 healthy subjects were recruited in this study. All
participants were Caucasians from the region of Puglia, Italy.
Table 1 shows details about the demographics of the sample,
while Table 2 shows information about subjects that participated
in multiple experiments. All subjects were evaluated with the
Structured Clinical Interview for the Diagnostic and Statistical
Manual of Mental Disorders (First et al., 1996), 4th Edition,
to exclude any psychiatric disorder. Along with the absence of
psychiatric conditions, other exclusion criteria were represented
by a history of significant drug or alcohol abuse, active drug use
in the previous year, head trauma with loss of consciousness,
and any significant medical condition. The present experimental
protocol was approved by the local institutional review board
at the Policlinico of Bari, Bari, Italy. After giving the subjects a
thorough description of the study, written informed consent was
obtained. All subjects underwent one or more of the procedures
described below.
GENOTYPE DETERMINATION
Subjects were genotyped for DRD2 rs1076560 in our labora-
tory through a previously described allele-specific primer PCR
approach (Papp et al., 2003; Bertolino et al., 2009a, 2010;
Blasi et al., 2009, 2011; Fazio et al., 2011; Sambataro et al.,
2013). Briefly, a MiniOpticon 48-well Real Time PCR Sys-
tem (Biorad) was used for PCR amplification and subsequent
fluorescence melting curve analysis on a 25-uL volume of
PCR reaction. Primers with differential melting temperatures
(Tm) were obtained by introducing a random guanine-
cytosine (GC) segment at the 5’ end of one specific for-
ward primer. Specifically, the GC clamp was added to the
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Table 1 | Demographics of the subjects included in the study.
N Age∗ Sex HolloingShead∗ Handedness∗ QI∗ SPQ∗
Association of SPQ scores with rs1076560
GG 42 27.7 ± 5.8 20 m 33.2 ± 15 0.7 ± 0.5 107.9 ± 14.4 7.4 ± 4.9
GT 25 25.4 ± 5.5 6 m 35.3 ± 12.4 0.8 ± 0.2 103.6 ± 8.4 11.7 ± 7.7
fMRI
GG 55 27.2 ± 5.3 20 m 38.4 ± 17.3 0.74 ± 0.4 112.5 ± 12.4 7.98 ± 5.9
GT 13 22.9 ± 3 4 m 33.96 ± 15.6 0.63 ± 0.57 106.5 ± 12.9 7.92 ± 4.5
SPECT study
GG 17 23.6 ± 3.33 8 m 41.4 ± 17.5 0.68 ± 0.4 113.11 ± 15.4 9.7 ± 9.6
GT 9 23 ± 3.3 5 m 38.7 ± 9.8 0.8 ± 0.2 107 ± 16.6 6.1 ± 5.4
* mean ± SD.
Table 2 | Number of subjects that participated in multiple
experiments and genotype distribution.
Total subjects GG GT
number
Ex1.Association of SPQ scores
with rs1076560 67 42 25
Ex2.fMRI 68 55 13
Ex3.SPECT study 26 17 9
Ex1+Ex2 22 18 4
Ex1+Ex3 8 4 4
Ex2+Ex3 10 8 2
Ex1+Ex2+Ex3 3 3 0
primer of the product with the highest initial Tm in order to
obtain a difference of 4◦C or more between the two alleles
(G vs. T).
Forward and reverse primers were titrated over a range of
50–900 nM, and allele-specific reactions were analyzed with
individual forward and reverse primer sets. The amplification
conditions consisted of a 10-min preincubation at 95◦C (acti-
vation of the Taq DNA polymerase), followed by 40 cycles of
denaturation at 95◦C for 15 s, and then primer annealing and
extension for 1 min at 60◦C. The fluorescence melting curve
was analyzed immediately after the amplification phase. SYBR
Green® fluorescent dye was used to visualize DNA binding using
fluorescence melting curves. Consistent with the distribution
observed in earlier studies (Zhang et al., 2005), no DRD2 TT
subjects were observed in this sample. The allelic distribution of
DRD2 showed a Hardy Weinberg equilibrium (df = 1, χ2 = 0.58,
p = 0.48).
SCHIZOTYPAL PERSONALITY QUESTIONNAIRE
All subjects completed the Schizotypal Personality Question-
naire (SPQ; Raine, 1991, 2006). The SPQ is a 74-item validated
self-report questionnaire with a “yes/no” response format that
incorporates DSM-III-R criteria (American Psychiatric Associ-
ation, 1987) for the diagnosis of SPD. The questionnaire con-
sists of nine subscales, which have been found to correspond
to three factors: cognitive-perceptual, interpersonal, and disorga-
nized factors. SPQ total scores were used.
ASSOCIATION OF SPQ WITH DRD2 rs1076560
A one-way ANOVA with the SPQ total score as the dependent
variable and the DRD2 rs1076560 genotype as the predictor
was used to test for the association of schizotypy and genetic
variability with rs1076560.
ASSOCIATION OF SPQ AND DRD2 rs1076560 WITH IMAGING
PHENOTYPES
SPECT
Twenty-six healthy subjects (17 GG, 9 GT) underwent SPECT
with [123I]IBZM radiotracer, which binds to D2 receptors (Kung
et al., 1990). Each individual was intravenously injected with
an average of 150 MBq (range: 111–186 MBq) of commercially
available IBZM radiotracer (GE Healthcare, USA) (Meyer et al.,
2008). Potassium iodide solution (Lugol) was administered at
least 3 h before and 12 h after radiopharmaceutical injection to
block the thyroid uptake of free radioactive iodide. Images were
acquired 1.5 h after IBZM injection (Brücke et al., 1991). A dual-
head gamma camera (Infinia, GE Healthcare, USA) equipped
with parallel-hole low-energy high-resolution collimators was
used. SPECT data were acquired using the following parameters:
128 × 128 matrix, a rotation of 360◦, 6◦ view angle, 45 s for
projection. The slice thickness was 3.68 mm, the acquisition
time was 22 min, and total brain counts of >1 million were
achieved in all examinations. Reconstruction was performed by
a filtered back projection with a Butterworth filter (cut-off fre-
quency: 0.3 cycle/cm, 10th order) to provide transaxial slices.
The attenuation correction was performed according to Chang’s
method (attenuation coefficient: 0.12 cm−1) after manually draw-
ing an ellipse around the head contour (Tatsch et al., 2002).
The system’s spatial resolution (full width at half-maximum)
at a radius of rotation of 15.9 cm was 11 mm, as reported
elsewhere (Soret et al., 2003). For the analysis of the striatal radio-
tracer uptake, slices were reoriented parallel to the canthomeatal
line.
SPECT data processing
The irreversible binding characteristics and the uptake stabil-
ity of the regional IBZM radiotracer for the D2 receptor have
been shown to allow for the estimation of the specific-to-
nondisplaceable equilibrium partition coefficient (V3′′), which is
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proportional to the free transporter or receptor density (Bmax)
(Laruelle et al., 1994; Frankle et al., 2004). V3′′ can be calculated
as indicated earlier (Laruelle et al., 1994; Scherfler et al., 2005).
Under equilibrium conditions between a compartment with spe-
cific binding and a compartment representing nonspecifically
bound and free activity, V3′′ is proportional to Bmax given that
the dissociation constant and the volume of distribution of the
nonspecifically bound and free activity compartment (V2) are
relatively invariant. The occipital region was selected as the back-
ground region because (1) the density of dopamine D2 receptors
is negligible compared with the striatum (Lidow et al., 1989);
(2) this region can be identified with greater reliability than the
cerebellum (Laruelle et al., 1996); and (3) in humans, IBZM
activity in the occipital region is equal to the nonspecific activity
in the striatum (Seibyl et al., 1992).
Therefore, as in earlier studies (Verhoeff et al., 1993; Laruelle
et al., 1996; Beukers et al., 2009), the occipital region was used to
model the nonspecifically bound and free activity compartment.
V3′′ was calculated in all voxels with the formula reported below
as in previous studies (Scherfler et al., 2005; Bertolino et al., 2010):




where VT represents specific binding, and V2 is the nonspecif-
ically bound and free activity compartment. The image trans-
formation, the calculation of V3′′, and the statistical analysis
were performed using SPM8 (Wellcome Department of Cognitive
Neurology, London, UK). V2 was calculated with the ROI of
the occipital lobe from WFU PickAtlas software version 1.04
(Functional MRI Laboratory at the Wake Forest University School
of Medicine),1 (Lancaster et al., 2000; Tzourio-Mazoyer et al.,
2002; Maldjian et al., 2003).
Since the parametric images of IBZM V3′′ lack anatomical
detail, an indirect approach was employed for the spatial nor-
malization, as detailed in previous studies (Rakshi et al., 1999;
Scherfler et al., 2005). Briefly, the raw IBZM SPECT data of
each subject were normalized on the SPECT template in MNI
(Montreal Neurological Institute) space (Scherfler et al., 2005)
with a 12-parameter affine transformation of the raw data onto
the template image followed by the estimation of the nonlinear
deformations between the applied images. A mean image of
previously normalized raw data acquisitions was then computed
and used as a template image. For each individual SPECT acqui-
sition, a parametric V3′′ image was calculated. The raw data
image was transformed into the template image, and the resulting
transformation parameters were then applied to the parametric
V3′′ image of the corresponding subject. The spatially normalized
parametric images were convolved with a Gaussian kernel (6 × 6
× 6 mm) for smoothing.
Group analysis was performed using a general linear model
with the V3′′ binding of IBZM as the dependent variable, the
DRD2 genotype as a categorical predictor, and SPQ scores as a
continuous predictor. Separate contrasts were thus performed to
detect the directionality of the correlations (i.e., positive or nega-
tive) associated with psychometric schizotypy for each genotype
1http://fmri.wfubmc.edu/cms/software#PickAtlas
group. We used a statistical threshold of p < 0.05 with the
family-wise error small-volume corrected (Genovese et al., 2002)
using the whole putamen ROI followed by a voxel-based analysis.
Regions of interest were created using WFU PickAtlas software
version 1.04.1 The results are significant after correction for the
total number of voxel-wise comparisons.
fMRI
Sixty-eight healthy subjects (55 GG and 13 GT) underwent fMRI
while performing the variable attentional control (VAC) task,
which elicits increasing demand for attentional control and was
identical to the one published in previous studies (Blasi et al.,
2005, 2007, 2010, 2011, 2013a,b; Zhang et al., 2007). The VAC
task allows for the investigation of brain activity during three
levels of attentional control (low, intermediate, high), which
were obtained while manipulating both the relative directions of
arrows with different sizes and related cue words.
Each stimulus of the VAC task was composed of arrows of three
different sizes pointing either to the right or to the left, and small
arrows were embedded in medium-sized arrows that were in turn
embedded in a large arrow. Subjects were instructed by a cue word
(big, medium, or small) displayed above each stimulus to press a
button corresponding to the direction of the large, medium, or
small arrows (right or left). To increase the level of attentional
control required, the direction of the arrows was congruent or
incongruent for all three sizes. This resulted in the following
conditions:
• Low level of attentional control. All three sizes of arrows were
congruent in direction with each other. The cue was the word
BIG.
• Intermediate level of attentional control. Two types of stimuli
were used, and the big arrow was incongruent in direction to
the small and medium arrows in both: the cue was BIG in one
of them and SMALL in the other.
• High level of attentional control. Two types of stimuli were
used, and the medium-sized arrows were incongruent in direc-
tion to the big and small arrows in both: the cue was SMALL in
one of them, MEDIUM in the other.
• A simple bold arrow pointing either to the left or to right was
used as a sensorimotor control condition.
Subjects were instructed to respond to the task stimuli with the
right hand using a button box (with a right button for the “right”
response and a left button for the “left” response) and to press the
response button as fast and as accurately as possible. Furthermore,
they were asked to move their thumb onto a small plastic knob
placed between buttons after each response. All subjects were
trained on the task before the fMRI session. Each stimulus was
presented for 800 ms, and the order of the stimuli was randomly
distributed throughout the session. The total number of stimuli
was 241: 50 HIGH (25 stimuli of each of the two stimulus types
that subtended this level of attentional control), 68 INT (34
stimuli of each of the two stimulus types that subtended this
level of attentional control), 57 LOW, and 66 simple bold arrows
(sensorimotor control condition). The total duration of the task
was 10 min and 8 s. A fixation cross-hair was presented during
the inter-stimulus interval, which ranged from 2,000 to 6000
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ms. Stimuli were presented using a back-projection system, and
responses were recorded through a fiber-optic response box that
allowed the accuracy and reaction time to be measured for each
trial. In order to maximize the detection of the effects of interest,
focus was centered on the analysis of the high level of attentional
control elicited by the VAC task.
fMRI data acquisition
Blood oxygen level-dependent (BOLD) fMRI was performed on a
GE Signa 3T scanner (General Electric, Milwaukee, WI) equipped
with a standard quadrature head coil. A gradient-echo planar
imaging sequence (repetition time: 2000 ms; echo time: 28 ms;
26 interleaved axial slices; thickness: 4 mm; gap: 1 mm; voxel size:
3.75 isotropic; scan repetition: 300; flip angle: 90◦; field of view:
24 cm; matrix: 64× 64) was used to acquire images while subjects
performed the VAC task. The first four scans were discarded to
allow for signal saturation. Images for each subject were realigned,
spatially normalized into the MNI template (12-parameter affine
model), and spatially smoothed (10-mm Gaussian filter). After
realignment, datasets were also checked for small-motion correc-
tion (<2 mm in translation,<1.5◦ in rotation).
fMRI data processing
fMRI responses were modeled using a canonical hemodynamic
response function and temporally filtered using a 128-Hz high-
pass filter and an hrf-shape low-pass filter. Vectors were created
for each condition using the timing of the correct responses.
To account for differences in head movement between groups,
residual movement was also modeled as a regressor of no inter-
est. A t-statistic was then used to produce a statistical image
for BOLD responses relative to the brain processing of stimuli
for each level of attentional control (HIGH, INT, and LOW).
Group analysis was performed using a general linear model
with BOLD response at the high level of attentional control
(HIGH) as the dependent variable in order to maximize the
effects of interest. The DRD2 rs1076560 genotype was used
as the categorical predictor and SPQ scores as the continuous
predictor. Separate contrasts were thus performed to detect the
directionality of the correlations (i.e., positive or negative) asso-
ciated with SPQ scores for each DRD2 genotype. We used a
statistical threshold of p < 0.05 which was family-wise error
small-volume corrected using regions of interest and created
using WFU PickAtlas software version 1.04.1 The dorso-lateral
pre-frontal cortex (DLPFC; BA9/46) and the anterior cingulate
cortex (BA24/32), which are crucially associated with atten-
tional control and are modulated by dopamine signaling (Blasi
et al., 2007, 2010, 2011), were considered as regions of interest.
Brodmann’s areas were assigned to activated clusters using the
Talairach Daemon.2 All coordinates are reported in the MNI
system.
ANALYSIS OF BEHAVIORAL DATA
Multiple regression was performed to investigate the behavioral
performance on the VAC. In particular, accuracy or reaction time
at the high level of attentional control (HIGH) was used as the
2http://www.talairach.org/daemon.html
dependent variables, DRD2 rs1076560 was used as the categorical
predictor, and SPQ scores were the continuous predictor.
RESULTS
SPQ AND DRD2 rs1076560
Genotype groups were matched for age (F = 1.4, p = 0.3), IQ
(F = 0.37, p = 0.5), handedness (F = 1.82, p = 0.2), and gender
(χ2 = 3.6, p = 0.1). The one-way ANOVA with the SPQ total score
as the dependent variable and the DRD2 rs1076560 genotype as
the predictor showed a main effect of the genotype on SPQ scores
(F1,65 = 7.5, p = 0.008), with GT individuals having greater scores
than GG subjects.
SPQ, DRD2 rs1076560 AND IBZM BINDING
SPM multiple regression analysis was performed to investigate
the association of IBZM binding in healthy individuals with
SPQ scores per se and as a function of rs1076560 genotype.
Genotype groups were matched for age (F = 0.2, p = 0.7),
IQ (F = 0.75, p = 0.4), handedness (F = 1.3, p = 0.3), and
gender (χ2 = 0.17, p = 0.7). SPM multiple regression anal-
ysis between IBZM binding as the dependent variable, the
DRD2 rs1076560 genotype as the categorical predictor, and
the SPQ score as the continuous predictor indicated an inter-
action between SPQ scores and genotype in the right puta-
men (x:30; y:−12; z:12; z = 4.67, p = 0.001) (Figure 1A).
In particular, a positive regression between IBZM binding and
SPQ scores was present in GT individuals (z = 4.81, p =
0.001), while there was no significant correlation in GG subjects
(Figure 1B).
SPQ, DRD2 rs1076560 AND BRAIN ACTIVITY DURING ATTENTIONAL
CONTROL
Genotype groups were matched for age (F = 3.3, p = 0.1),
IQ (F = 0.5, p = 0.5), handedness (F = 0.4, p = 0.5) and
gender (χ2 = 0.14, p = 0.7). SPM multiple regression analy-
sis was performed to investigate if brain activity during atten-
tional control in healthy individuals was predicted by SPQ scores
per se and as a function of rs1076560 genotype. This analysis
indicated an interaction between SPQ scores and rs1076560 on
DLPFC activity (x:−44, y:27, z:40; z = 3.4, p = 0.028; BA9)
(Figure 2A). In particular, a negative regression between dor-
solateral prefrontal activity during the high load of attentional
control elicited by the VAC task and SPQ scores was present in
GT subjects (z = 3.80, p = 0.009), while there was no significant
correlation in GG individuals (Figure 2B). No other significant
results were observed in different ROIs such as BA46, BA32 and
BA24.
SPQ, DRD2 rs1076560 AND BEHAVIORAL PERFORMANCE ON THE VAC
There was a main effect of rs1076560 (F = 4.3, p = 0.04), no main
effect of SPQ (F = 0.4, p = 0.5), and a statistical trend for an
interaction between rs1076560 and SPQ (F = 3.5, p = 0.06) on
accuracy with a high load of the VAC task. Furthermore, there
was a trend toward significance of the entire model (multiple
R = 0.3, multiple R2 = 0.08, adjusted R2 = 0.04, F = 1.98,
p = 0.1). In particular, a negative relationship between behav-
ioral performance in terms of accuracy at high load of the
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FIGURE 1 | (A) Axial section of the brain showing the interaction between rs1076560 and SPQ scores on IBZM binding V3′′ in the right putamen. (B) IBZM
binding V3′′ extracted from the right putamen cluster illustrated in (A).
FIGURE 2 | (A) Rendered image of the brain showing the interaction between rs1076560 and SPQ scores on fMRI response during attentional control in left
BA9 (x:−44, y :27, z:40). (B) Parameter estimates extracted from the cluster in BA9 cluster illustrated in (A).
VAC task and SPQ scores was present in GT subjects, while
this relationship was not present in GG individuals (Figure 3).
We did not find a main effect of rs1076560 and SPQ or
their interaction on the VAC task high-load reaction time (All
F < 0.6, p > 0.4). Also, a regression model with rs1076560
and SPQ as regressors and high-load reaction time as the
dependent variable did not show any effect as a whole (multiple
R = 0.12, multiple R2 = 0.013, adjusted R2 = −0.03, F = 0.29,
p = 0.8).
DISCUSSION
We investigated whether schizotypy is related to genetic vari-
ation within the DRD2 gene and whether they interact on a
series of phenotypes implicated in schizophrenia. We found
that DRD2 rs1076560 is associated with SPQ scores in healthy
subjects. Furthermore, we report an interaction between SPQ
scores and the rs1076560 genotype on striatal IBZM bind-
ing. This interaction is also present on prefrontal activity
during attentional processing. Interaction between SPQ scores
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FIGURE 3 | Scatterplot showing the relationship between rs1076560,
SPQ scores, and % accuracy in the VAC task. See text for statistics.
and genotype is coherently evident on attentional performance
at the behavioral level, but it does not reach full statistical
significance.
Previous studies have found higher measures of schizotypy
in first-degree relatives of patients with schizophrenia compared
with healthy subjects (Kety et al., 1994; Kendler et al., 1995;
Tsuang et al., 1999; Vollema et al., 2002), suggesting that this
trait is related to risk for this disorder. Our findings indicate
that rs1076560 GT subjects have greater SPQ scores than GG
individuals and are in line with previous reports suggesting
that the T allele increases risk for several biological pheno-
types associated with schizophrenia, including inefficient cortical
and subcortical responses during cognitive processing (Zhang
et al., 2007; Bertolino et al., 2010; Blasi et al., 2011), as well as
low “pre-” and “post-” synaptic D2 receptor availability, possibly
reflecting greater levels of striatal dopamine signaling (Bertolino
et al., 2010).
Previous radiotracer imaging studies indicated that the steady-
state and stimulus-induced release of dopamine in the striatum
and D2 binding are associated with schizotypy (Abi-Dargham
et al., 2004; Soliman et al., 2008; Woodward et al., 2011; Chen
et al., 2012). Consistently, we report an interaction between SPQ
scores and the rs1076560 genotype on striatal IBZM binding.
Our results demonstrate that only GT subjects show a positive
correlation between IBZM binding in the right putamen and
SPQ scores. Such a correlation was not found in GG indi-
viduals. Even though the specificity of IBZM binding for the
two D2 isoforms is still uncertain, IBZM is believed to bind
post-synaptic D2 receptors (Kung et al., 1990; Nyberg et al.,
2009). Therefore, our results suggest that individuals carrying
the T allele with greater schizotypy scores have a greater post-
synaptic D2 receptor density. Notably, the T allele group is
also associated with a lower ratio of expression between D2S
and D2L. Together with previous evidence indicating that the
T allele of rs1076560 is a risk factor for phenotypes associ-
ated with schizophrenia (Zhang et al., 2007; Bertolino et al.,
2009a,b, 2010; Blasi et al., 2009, 2011; Fazio et al., 2011), this
knowledge suggests that schizotypy in healthy subjects may
be mapped onto the Gaussian distribution of schizophrenia
risk.
Previous studies have demonstrated that higher-order cogni-
tion and related prefrontal activity are strongly modulated by cor-
tical and subcortical dopamine D2 signaling and related genetic
variation (Zhang et al., 2007; Tan et al., 2008; Bertolino et al.,
2009a). Our fMRI results are consistent with these findings and
provide further evidence that DRD2 functional variation interacts
with schizotypy in modulating the attention-related prefrontal
response. In particular, we found a negative correlation between
behavioral performance, prefrontal activity during attentional
processing, and SPQ scores only in GT individuals. In other
words, higher schizotypy scores in this subgroup of individuals
are related to lower prefrontal activity during attentional con-
trol. Similar results were found when looking at the interaction
between SPQ scores and the rs1076560 genotype on behavioral
accuracy in the VAC task. There was a statistical trend suggesting
that higher SPQ scores predict lower accuracy in the task in
GT individuals only. The fact that this finding does not reach
statistical significance is consistent with the greater biological gap
between gene effects and behavior compared with physiological
responses, thus requiring greater sample sizes to detect significant
effects.
Altogether, these fMRI and behavioral results add evidence
to the relevance of the interaction between this construct of
personality and genetic variation in DRD2 in modulating brain
physiology during attentional processes. Additionally, they are
again consistent with the relationship between schizotypy in
healthy subjects and the schizophrenia continuum. Consistently,
previous studies have indicated that patients with schizophre-
nia have abnormal prefrontal activity and worse behavioral
performance during attentional processing (Weiss et al., 2003;
Honey et al., 2005; Kerns et al., 2005; Laurens et al., 2005;
MacDonald et al., 2005; Gur et al., 2007). Furthermore, evi-
dence of abnormal prefrontal activity has been reported during
cognitive processing in patients with schizophrenia carrying the
rs1076560 T allele (Bertolino et al., 2009a,b, 2010; Blasi et al.,
2010).
A limitation of this study is that the sample used for fMRI,
SPECT, and SPQ investigations do not overlap. Another limita-
tion is that we investigated the scores of schizotypy in healthy
subjects, thus leaving the relationship between schizophrenia as
a diagnostic category and the present findings an open question.
However, our results are consistent overall in indicating the rele-
vance of the interaction between schizotypy and rs1076560 for the
phenotypes measured in the present study.
In conclusion, we have provided evidence for a modula-
tion of imaging phenotypes of relevance to schizophrenia by
the interaction between complex personality traits and simple
genetic variations. These findings open new scenarios for the
study of sub-threshold correlates adding risk for this brain
disorder.
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